Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Kohei,Horiuchi ^[1] ; Takashi,Sato ^[2] ; Toshiki,Kuno ^[3] ; Hisato,Takagi ^[4] ; Fred R,Hirsch ^[5] ; Charles A,Powell ^[6] ; Koichi,Fukunaga ^[1]

作者单位： Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. ^[1] Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Medicine, Keiyu Hospital, Yokohama, Japan; Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan. Electronic address: takashisato@keio.jp. ^[2] Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA. ^[3] Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizouka, Japan. ^[4] Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[5] Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[6]

关键词 Chemotherapy Meta-analysis Platinum-doublet Re-challenge Second-line treatment Small-cell lung cancer

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);肿瘤复发, 局部(Neoplasm Recurrence, Local);小细胞肺癌(Small Cell Lung Carcinoma)

DOI 10.1016/j.lungcan.2021.04.013

PMID 33894495

发布时间 2021-06-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交